US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recordati Industria Chimica e Farmaceutica S.p.A.

65.44

0.0000

Volume:- -

Turnover:- -

Market Cap:13.69B

PE:33.00

High:65.44

Open:65.44

Low:65.44

Close:65.44

52wk High:65.44

52wk Low:49.00

Shares:209.13M

Float Shares:98.37M

Volume Ratio:0.22

T/O Rate:- -

Dividend:1.50

Dividend Rate:2.29%

EPS(TTM):1.98

EPS(LYR):2.09

ROE:22.16%

ROA:9.34%

PB:6.24

PE(LYR):31.28

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Recordati Industria Chimica e Farmaceutica S.p.A.

Exchange:

PINK LIMITED

Establishment Date:

1926

Employees:

4539

Office Location:

Via Matteo Civitali,1,Milan,Milan,Italy

Website:

http://www.recordati.com

Zip Code:

20148

Phone:

Fax:

39 02 40073747

Introduction:

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RCDTF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RCDTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RCDTF\",,,,,undefined,":{"symbol":"RCDTF","market":"US","secType":"STK","nameCN":"Recordati Industria Chimica e Farmaceutica S.p.A.","latestPrice":65.44,"timestamp":1757102400000,"preClose":65.44,"halted":0,"volume":0,"delay":15,"floatShares":98365990,"shares":209125200,"eps":1.983285,"marketStatus":"Market Closed","change":0,"latestTime":"09-05 16:00:00 EDT Delay","open":65.44,"high":65.44,"low":65.44,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.983285,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":65.44,"volumeRatio":0.21523150300463179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RCDTF\",,,,,undefined,":{"symbol":"RCDTF","floatShares":98365990,"roa":"9.34%","roe":"22.16%","lyrEps":2.092129,"volumeRatio":0.21523150300463179,"shares":209125200,"dividePrice":1.5,"high":65.44,"amplitude":0,"preClose":65.44,"low":65.44,"week52Low":49,"pbRate":"6.24","psRate":"4.71","week52High":65.44,"institutionHeld":0,"latestPrice":65.44,"eps":1.983285,"divideRate":0.022922,"volume":0,"delay":15,"ttmEps":1.983285,"open":65.44,"prevYearClose":55.54,"prevWeekClose":65.44,"prevMonthClose":65.44,"prevQuarterClose":65.44,"fiveDayClose":65.44,"twentyDayClose":65.44,"sixtyDayClose":56.0428},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCDTF\",params:#limit:5,,,undefined,":[{"date":"2025-05-19","symbol":"RCDTF","amount":0.67,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-20","defaultRemindTime":1747661400000,"name":"Recordati Industria Chimica e Farmaceutica S.p.A.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-21","payableDate":"2025-05-20","currency":"EUR","dateTimestamp":1747627200000,"payDate":"2025-05-21"},{"date":"2024-11-18","symbol":"RCDTF","amount":0.6,"announcedDate":"2024-11-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-19","defaultRemindTime":1731940200000,"name":"Recordati Industria Chimica e Farmaceutica S.p.A.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-20","payableDate":"2024-11-19","currency":"EUR","dateTimestamp":1731906000000,"payDate":"2024-11-20"},{"date":"2024-05-20","symbol":"RCDTF","amount":0.63,"announcedDate":"2024-03-19","type":"dividend","market":"US","newRecordDate":"2024-05-21","defaultRemindTime":1716211800000,"name":"Recordati Industria Chimica e Farmaceutica S.p.A.","recordDate":"2024-05-22","payableDate":"2024-05-21","currency":"EUR","dateTimestamp":1716177600000,"payDate":"2024-05-22"},{"date":"2024-05-09","symbol":"RCDTF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715241600000,"name":null,"time":"","dateTimestamp":1715227200000,"actualEps":null},{"date":"2023-11-20","symbol":"RCDTF","amount":0.57,"announcedDate":"2023-01-17","type":"dividend","market":"US","newRecordDate":"2023-11-21","defaultRemindTime":1700490600000,"name":"Recordati Industria Chimica e Farmaceutica S.p.A.","recordDate":"2023-11-22","payableDate":"2023-11-21","currency":"EUR","dateTimestamp":1700456400000,"payDate":"2023-11-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCDTF\",market:\"US\",,,undefined,":[{"executeDate":"2019-04-23","recordDate":"2019-04-24","paymentDate":"2019-04-25","value":0.47,"currency":"EUR"},{"executeDate":"2019-11-18","recordDate":"2019-11-19","paymentDate":"2019-11-20","value":0.48,"currency":"EUR"},{"executeDate":"2020-05-18","recordDate":"2020-05-19","paymentDate":"2020-05-20","value":0.52,"currency":"EUR"},{"executeDate":"2020-11-23","recordDate":"2020-11-24","paymentDate":"2020-11-25","value":0.5,"currency":"EUR"},{"executeDate":"2021-05-24","recordDate":"2021-05-25","paymentDate":"2021-05-26","value":0.55,"currency":"EUR"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RCDTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.1818,"hold":0.4545,"sell":0.0909,"strongSell":0,"meanLabel":"BUY","meanPercent":0.1818,"analysts":11,"updateTime":1754971200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":687223,"yearFounded":1926,"employeeNum":4539,"address":"Via Matteo Civitali,1,Milan,Milan,Italy","zipCode":"20148","officePhone":"39 02 487871","officeFax":"39 02 40073747"},"stockCompanyDetail":{"websiteUrl":"http://www.recordati.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.0714},{"period":"ytd","weight":-0.0714}],"description":"Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.","exchange":"PINK LIMITED","name":"Recordati Industria Chimica e Farmaceutica S.p.A.","nameEN":"Recordati Industria Chimica e Farmaceutica S.p.A."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RCDTF\",market:\"US\",,,undefined,":null}}